EGFR blockade confers sensitivity to cabozantinib in hepatocellular carcinoma.

More about this publication

Cell discovery
  • Volume 8
  • Issue nr. 1
  • Pages 82
  • Publication date 23-08-2022

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.